Chikungunya Vaccine Candidate Induces Strong Immune Response
TUESDAY, June 13, 2023 (HealthDay News) — The live attenuated vaccine candidate for active immunization and prevention of disease caused by chikungunya virus, VLA1553, induces a strong immune response and seroprotective titers in almost all vaccinate…
Learn More